Marco Sardella joined the company in 2015. He is Chief Pharmacovigilance Officer and European Qualified Person for Pharmacovigilance (EEA QPPV) of ADIENNE. In this role, he is globally responsible for the safety of products under investigation and/or available on the markets. He leads the Pharmacovigilance and Risk Management teams. He graduated in Pharmaceutical Chemistry and Technologies from the University of Sassari (Italy). Previously, he was in charge as EEA QPPV and Head of Safety in Gentium SpA (Jazz Pharmaceuticals).